- Myelomatous effusion with poor response to chemotherapy
-
Kim YM, Lee KK, Oh HS, Park SK, Won JH, Hong DS, Park HS, Park JS, Lee DW
- KMID: 648132
- J Korean Med Sci.
- 2000 Apr;15(2):243-246.
- doi: 10.3346/jkms.2000.15.2.243
While pleural effusion in multiple myeloma is relatively infrequent, myelomatous pleural effusion is extremely rare. We experienced a 61-year-old woman with IgD-lambda multiple myeloma and pleural effusion. The diagnosis was... -
- CITED
-
- Close
- SHARE
-
- Close
- Autoimmune Hepatitis: Recent Update on Diagnosis and Treatment
-
Lee YS
- KMID: 760666
- Korean J Hepatol.
- 2006 Sep;12(3):318-332.
Autoimmune hepatitis (AIH) is an unresolving, predominantly periportal hepatitis that is usually displays hypergammaglobulinemia, and tissue autoantibodies, and this malady is responsive to immunosuppressive therapy. Our understanding about this clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab
-
Lim KH, Yoon HI, Kang YA, Lee KW, Kim JH, Bang SM, Lee JH, Lee CT, Lee JS
- KMID: 1785660
- Korean J Intern Med.
- 2010 Mar;25(1):86-92.
- doi: 10.3904/kjim.2010.25.1.86
BACKGROUND/AIMS: The aim of our study was to determine the incidence and clinical features of severe pulmonary complications in patients receiving cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or rituximab plus... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Focal Segmental Glomerulosclerosis Associated with Aplastic Anemia
-
Park CY, Kim DM, Cho YS, Yoon SH, Chung JH, Chung CH, Kim HL
- KMID: 1778577
- J Korean Med Sci.
- 2004 Dec;19(6):898-900.
- doi: 10.3346/jkms.2004.19.6.898
The pathogenic mechanism of focal segmental glomerulosclerosis (FSGS) and aplastic anemia are associated with immunologic events which lead to glomerular cell injury or hematopoietic cell destruction. We present an extremely... -
- CITED
-
- Close
- SHARE
-
- Close
- Adult T-cell leukemia/lymphoma in a Korean: a case report
-
Lee SS, Hong SI, Lee DS, Kang YK, Kim CW, Jang JJ
- KMID: 644836
- J Korean Med Sci.
- 1994 Dec;9(6):458-465.
- doi: 10.3346/jkms.1994.9.6.458
The clinicopathologic features of a Korean patient with adult T-cell leukemia/lymphoma(ATLL) are presented. A 51-year-old man, who has lived in Korea since birth, had multiple cutaneous nodules and multiple lymphadenopathy... -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
-
Choi YW, Jeong SH, Ahn MS, Lee HW, Kang SY, Choi JH, Jin UR, Park JS
- KMID: 2069930
- J Korean Med Sci.
- 2014 Nov;29(11):1493-1500.
- doi: 10.3346/jkms.2014.29.11.1493
Febrile neutropenia (FN) is the major toxicity of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen in the treatment of diffuse large B-cell lymphoma (DLBCL). The prediction of neutropenia... -
- CITED
-
- Close
- SHARE
-
- Close
- Modified Number of Extranodal Involved Sites as a Prognosticator in R-CHOP-Treated Patients with Disseminated Diffuse Large B-Cell Lymphoma
-
Yoo C, Kim S, Sohn BS, Kim JE, Yoon DH, Huh J, Lee DH, Kim SW, Lee JS, Suh C
- KMID: 1776612
- Korean J Intern Med.
- 2010 Sep;25(3):301-308.
- doi: 10.3904/kjim.2010.25.3.301
BACKGROUND/AIMS: Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (R-CHOP) has improved survival in patients with diffuse large B-cell lymphoma (DLBCL) and weakened the prognostic power of the international prognostic... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance of nuclear factor kappaB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy
-
Shin HC, Seo J, Kang BW, Moon JH, Chae YS, Lee SJ, Lee YJ, Han S, Seo SK, Kim JG, Sohn SK, Park TI
- KMID: 2070136
- Korean J Intern Med.
- 2014 Nov;29(6):785-792.
- doi: 10.3904/kjim.2014.29.6.785
BACKGROUND/AIMS: This study investigated the expression of nuclear factor kappaB (NF-kappaB) and the chemokine receptor (CXCR4) in patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab-based therapy. METHODS: Seventy patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcomes with CHOP Chemotherapy in Adult Patients with Hemophagocytic Lymphohistiocytosis
-
Shin HJ, Chung JS, Lee JJ, Sohn SK, Choi YJ, Kim YK, Yang DH, Kim HJ, Kim JG, Joo YD, Lee WS, Sohn CH, Lee EY, Cho GJ
- KMID: 1786882
- J Korean Med Sci.
- 2008 Jun;23(3):439-444.
- doi: 10.3346/jkms.2008.23.3.439
The objective of the current study was to investigate the treatment outcomes for the use of cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP) chemotherapy in adult patients with hemophagocytic lymphohistiocytosis (HLH).... -
- CITED
-
- Close
- SHARE
-
- Close
- Sweet's syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid
-
Park CJ, Bae YD, Choi JY, Heo PS, Lee KS, Park YS, Lee JA
- KMID: 759563
- Korean J Intern Med.
- 2001 Sep;16(3):218-221.
All-trans retinoic acid (ATRA) is the standard induction treatment for acute promyelocytic leukemia (APL). Quite many ATRA-related side effects, including retinoic acid syndrome, were reported. So far, it has rarely... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
-
Choi CH, Song ID, Kim YH, Koo JS, Kim YS, Kim JS, Kim N, Kim ES, Kim JH, Kim JW, Kim TO, Kim HS, Kim HJ, Park YS, Park DI, Park SJ, Song HJ, Shin SJ, Yang SK, Ye BD, Lee KM, Lee BI, Lee SY, Lee CK, Im JP, Jang BI, Jeon TJ, Cho YK, Chang SK, Jeon SR, Jung SA, Jeen YT, Cha JM, Han DS, Kim WH, IBD Study Group of the Korean Association for the Study of the Intestinal Diseases
- KMID: 2427155
- Yonsei Med J.
- 2016 Nov;57(6):1376-1385.
- doi: 10.3349/ymj.2016.57.6.1376
PURPOSE: Infliximab is currently used for the treatment of active Crohn's disease (CD). We aimed to assess the efficacy and safety of infliximab therapy and to determine the predictors of... -
- CITED
-
- Close
- SHARE
-
- Close
